AgeX Therapeutics Inc. (was merged with Biotechnology Serina Therapeutics (NYSE: SER) on 27/04/2024) (AGE)
New Form 8-K - Serina Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001708599-25-000091 Size: 352 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
There are no comments here yet...